insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

Reply to Letter Re: PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).

사설/논평 1/5 보강
Annals of oncology : official journal of the European Society for Medical Oncology 📖 저널 OA 24.1% 2022: 1/2 OA 2023: 1/3 OA 2024: 0/5 OA 2025: 1/25 OA 2026: 23/75 OA 2022~2026 2026 Vol.37(5) p. 746-747 Cancer Immunotherapy and Biomarkers
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-04-29
OpenAlex 토픽 · Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment Lung Cancer Treatments and Mutations

Frost N, Reck M

PubMed ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

↓ .bib ↓ .ris
APA N. Frost, M. Reck (2026). Reply to Letter Re: PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).. Annals of oncology : official journal of the European Society for Medical Oncology, 37(5), 746-747. https://doi.org/10.1016/j.annonc.2026.02.007
MLA N. Frost, et al.. "Reply to Letter Re: PET/CT-Guided Management of Immune Checkpoint Blockade and Post-Treatment Multi-Modal Profiling in Long-Term Responders with Metastatic Lung Cancer in the National Network Genomic Medicine Lung Cancer Germany (nNGM).." Annals of oncology : official journal of the European Society for Medical Oncology, vol. 37, no. 5, 2026, pp. 746-747.
PMID 41786570 ↗
DOI 10.1016/j.annonc.2026.02.007

같은 제1저자의 인용 많은 논문 (2)